DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
TELENZEPINE
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
TELENZEPINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0990EG3K10
Molecule Type:
Small molecule
Molecular Formula:
C19H22N4O2S
Molecular Weight:
370.48
AlogP:
2.53
PSA:
55.89
HBD:
1.0
HBA:
#RotB:
2.0
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
BMS-214662
1
Small molecule
Investigational
Unknown
Unknown
Anemia, Refractory, with Excess of Blasts; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
BMS-214662
×
Maximum Phase:
1
First Approval:
None
UNII:
L2U9GFD244
Molecule Type:
Small molecule
Molecular Formula:
C25H23N5O2S2
Molecular Weight:
489.63
AlogP:
4.17
PSA:
93.09
HBD:
1.0
HBA:
#RotB:
6.0
Source:
.ALPHA.-PYRROLIDINONONANOPHENONE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
.ALPHA.-PYRROLIDINONONANOPHENONE
×
Maximum Phase:
1
First Approval:
None
UNII:
S3FKL8RY1D
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO
Molecular Weight:
287.45
AlogP:
4.69
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
9.0
Source:
GSK-690693
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
cAMP-dependent protein kinase (PKA) inhibitor
GSK-690693
×
Maximum Phase:
1
First Approval:
None
UNII:
GWH480321B
Molecule Type:
Small molecule
Molecular Formula:
C21H27N7O3
Molecular Weight:
425.49
AlogP:
1.58
PSA:
137.14
HBD:
3.0
HBA:
#RotB:
5.0
Source:
RG7185
1
Small molecule
Investigational
Unknown
Unknown
Unknown
G protein-coupled receptor 44 antagonist
RG7185
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
9-ING-41
1
Small molecule
Investigational
Unknown
Unknown
Bone Neoplasms; Breast Neoplasms; Glioma; Kidney Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Sarcoma; Primary Myelofibrosis
Glycogen synthase kinase-3 beta inhibitor
9-ING-41
×
Maximum Phase:
1
First Approval:
None
UNII:
ND1SOF0DLU
Molecule Type:
Small molecule
Molecular Formula:
C22H13FN2O5
Molecular Weight:
404.35
AlogP:
3.36
PSA:
82.7
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CO-ZIDOCAPT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CO-ZIDOCAPT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C16H23ClN4O7S3
Molecular Weight:
515.04
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ASTAXANTHIN
1
Small molecule
Investigational
Unknown
Unknown
Metabolic Syndrome; Diabetic Neuropathies
Unknown
ASTAXANTHIN
×
Maximum Phase:
1
First Approval:
None
UNII:
8XPW32PR7I
Molecule Type:
Small molecule
Molecular Formula:
C40H52O4
Molecular Weight:
596.85
AlogP:
8.91
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
10.0
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
GSK1482160
1
Small molecule
Investigational
Unknown
Unknown
Pain
P2X purinoceptor 7 negative allosteric modulator
GSK1482160
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FK453
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor antagonist
FK453
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H25N3O2
Molecular Weight:
375.47
AlogP:
3.78
PSA:
57.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
XL-019
1
Small molecule
Investigational
Unknown
Unknown
Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential
Tyrosine-protein kinase JAK2 inhibitor
XL-019
×
Maximum Phase:
1
First Approval:
None
UNII:
4L1AM42NVA
Molecule Type:
Small molecule
Molecular Formula:
C25H28N6O2
Molecular Weight:
444.54
AlogP:
3.41
PSA:
91.41
HBD:
3.0
HBA:
#RotB:
6.0
Source:
PKI-166
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
PKI-166
×
Maximum Phase:
1
First Approval:
None
UNII:
9RIE5HW38P
Molecule Type:
Small molecule
Molecular Formula:
C20H18N4O
Molecular Weight:
330.39
AlogP:
4.5
PSA:
73.83
HBD:
3.0
HBA:
#RotB:
4.0
Source:
LY-2334737
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms
Unknown
LY-2334737
×
Maximum Phase:
1
First Approval:
None
UNII:
YLR364XYSA
Molecule Type:
Small molecule
Molecular Formula:
C17H25F2N3O5
Molecular Weight:
389.4
AlogP:
1.28
PSA:
113.68
HBD:
3.0
HBA:
#RotB:
8.0
Source:
SETANAXIB
1
Small molecule
Investigational
Unknown
Unknown
Idiopathic Pulmonary Fibrosis; Liver Cirrhosis, Biliary
Unknown
SETANAXIB
×
Maximum Phase:
1
First Approval:
None
UNII:
45II35329V
Molecule Type:
Small molecule
Molecular Formula:
C21H19ClN4O2
Molecular Weight:
394.86
AlogP:
3.4
PSA:
63.03
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TAS-115
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
TAS-115
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FF-10101
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 inhibitor
FF-10101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H38N8O2
Molecular Weight:
530.68
AlogP:
3.13
PSA:
126.28
HBD:
3.0
HBA:
#RotB:
13.0
Source:
CITARINOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Melanoma; Multiple Myeloma; Neoplasms
Unknown
CITARINOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
441P620G3P
Molecule Type:
Small molecule
Molecular Formula:
C24H26ClN5O3
Molecular Weight:
467.96
AlogP:
4.79
PSA:
107.45
HBD:
3.0
HBA:
#RotB:
11.0
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
FLUOROACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLUOROACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
AP1JV9U41M
Molecule Type:
Small molecule
Molecular Formula:
C2H3FO2
Molecular Weight:
78.04
AlogP:
0.04
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TBA-354
1
Small molecule
Investigational
Unknown
Unknown
Tuberculosis
Unknown
TBA-354
×
Maximum Phase:
1
First Approval:
None
UNII:
911T37M2WY
Molecule Type:
Small molecule
Molecular Formula:
C19H15F3N4O5
Molecular Weight:
436.35
AlogP:
3.73
PSA:
101.54
HBD:
0.0
HBA:
#RotB:
6.0
Source:
IRAMPANEL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Glutamate receptor ionotropic AMPA antagonist
IRAMPANEL
×
Maximum Phase:
1
First Approval:
None
UNII:
R2GZD7LMYX
Molecule Type:
Small molecule
Molecular Formula:
C18H19N3O2
Molecular Weight:
309.37
AlogP:
3.34
PSA:
51.39
HBD:
0.0
HBA:
#RotB:
6.0
Source:
AS-602868
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
AS-602868
×
Maximum Phase:
1
First Approval:
None
UNII:
Y1FZ8P93E0
Molecule Type:
Small molecule
Molecular Formula:
C18H14N4O3S
Molecular Weight:
366.4
AlogP:
3.01
PSA:
84.42
HBD:
1.0
HBA:
#RotB:
4.0
Source:
VT-1598
1
Small molecule
Investigational
Unknown
Unknown
Coccidioidomycosis
Unknown
VT-1598
×
Maximum Phase:
1
First Approval:
None
UNII:
AV9K9X720D
Molecule Type:
Small molecule
Molecular Formula:
C31H20F4N6O2
Molecular Weight:
584.53
AlogP:
4.88
PSA:
109.74
HBD:
1.0
HBA:
#RotB:
8.0
Source:
MSC-2364447
1
Small molecule
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Tyrosine-protein kinase BTK inhibitor
MSC-2364447
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIINDOLYLMETHANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIINDOLYLMETHANE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
CLX-0921
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Peroxisome proliferator-activated receptor gamma agonist
CLX-0921
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RELACATIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RELACATIB
×
Maximum Phase:
1
First Approval:
None
UNII:
BL51M8CB8R
Molecule Type:
Small molecule
Molecular Formula:
C27H32N4O6S
Molecular Weight:
540.64
AlogP:
2.9
PSA:
138.68
HBD:
2.0
HBA:
#RotB:
8.0
Source:
CORT125281
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CORT125281
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RO-4987655
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
RO-4987655
×
Maximum Phase:
1
First Approval:
None
UNII:
I3733P75ML
Molecule Type:
Small molecule
Molecular Formula:
C20H19F3IN3O5
Molecular Weight:
565.29
AlogP:
3.16
PSA:
100.13
HBD:
3.0
HBA:
#RotB:
8.0
Source:
1
2
…
76
77
78
79
80
81
82
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA